modipafant has been researched along with dihydropyridines in 29 studies
Studies (modipafant) | Trials (modipafant) | Recent Studies (post-2010) (modipafant) | Studies (dihydropyridines) | Trials (dihydropyridines) | Recent Studies (post-2010) (dihydropyridines) |
---|---|---|---|---|---|
29 | 3 | 3 | 5,022 | 529 | 969 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 15 (51.72) | 18.2507 |
2000's | 10 (34.48) | 29.6817 |
2010's | 4 (13.79) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cooper, K; Fray, MJ; Parry, MJ; Richardson, K; Steele, J | 1 |
Alabaster, VA; de Souza, RN; Keir, RF; Parry, MJ | 1 |
Nourshargh, S; Walsh, DT; Weg, VB; Williams, TJ | 1 |
Das, A; Larkin, SW; Nourshargh, S; Williams, TJ | 1 |
Angus, RM; Barnes, NC; Barnes, PJ; Bone, MF; Chung, KF; Fairfax, AJ; Higenbotham, TW; Kuitert, LM; O'Connor, BJ; Piotrowska, B | 1 |
Alabaster, VA; Cheeseman, HE; Cooper, K; deSouza, RN; Keir, RF; Parry, MJ | 1 |
Bolanowski, MA; Nourshargh, S; Sanz, MJ; Weg, VB | 1 |
Nourshargh, S; Sanz, MJ; Walsh, DT; Weg, VB; Williams, TJ | 1 |
Barnes, PJ; Carty, TJ; Chung, KF; Eskra, JD; O'Connor, BJ; Uden, S | 1 |
Barnes, NC; Burke, W; Hui, KP; Kuitert, LM; Newland, AC; Uden, S; Uthayarkumar, S | 1 |
Norman, KE; Nourshargh, S; Pons, F; Rossi, AG; Williams, TJ | 1 |
Jezequel, SG; Uden, S; Wastall, P | 1 |
Chilvers, ER; Condliffe, AM; Haslett, C; Kitchen, E; Rossi, AG | 1 |
Norman, KE; Rossi, AG; Williams, TJ | 1 |
Hellewell, PG; Jeffery, PK; Miotla, JM | 1 |
Aparecida, M; Beker, CL; Borges, CM; Freire-Maia, L; Silveira, MR; Teixeira, MM | 1 |
Andrade, SP; Cara, DC; Cassali, GD; Coutinho, SF; Poole, SP; Silveira, MR; Souza, DG; Teixeira, MM | 1 |
Au, BT; Collins, PD; Teixeira, MM; Williams, TJ | 1 |
Ishii, S; Nicoli, JR; Pinho, VS; Shimizu, T; Soares, AC; Souza, DG; Teixeira, MM | 1 |
Benjamim, CF; Cunha, Fde Q; Ferreira, SH; Rios-Santos, F; Zavery, D | 1 |
Ishii, S; Pinho, V; Shimizu, T; Soares, AC; Souza, DG; Teixeira, MM | 1 |
Andrade, SP; Barcelos, LS; Campos, PP; Ferreira, MA; Teixeira, MM; Vasconcelos, AC | 1 |
Arantes, EC; Coelho, AM; Coelho, FM; Pessini, AC; Pinho, VS; Souza, DG; Teixeira, AL; Teixeira, MM | 1 |
Bélanger, C; Borgeat, P; Elimam, H; Lefebvre, J; Marleau, S | 1 |
Amaral, FA; Atrasheuskaya, A; Bukin, E; Cunha, FQ; Fagundes, CT; Ignatyev, G; Kroon, EG; Sachs, D; Sousa, LP; Souza, AL; Souza, DG; Souza, RS; Teixeira, MM | 1 |
Borgeat, P; Flamand, N; Lefebvre, JS; Lévesque, T; Marleau, S; Milot, V; Picard, S | 1 |
Campos, RD; Lacerda-Queiroz, N; Quesniaux, VF; Rachid, MA; Rodrigues, DH; Soriani, FM; Sousa, LP; Teixeira, AL; Teixeira, MM; Vilela, MC | 1 |
Cunha, FQ; Cunha, TM; Ferreira, SH; Guerrero, AT; Pinto, LG; Verri, WA; Vieira, SM; Zaperlon, AC; Zarpelon, AC | 1 |
Campos, MA; de Miranda, AS; Kroon, EG; Lacerda-Queiroz, N; Lima, GK; Pedroso, VS; Rachid, MA; Rodrigues, DH; Teixeira, AL; Teixeira, MM; Vilela, MC | 1 |
3 trial(s) available for modipafant and dihydropyridines
Article | Year |
---|---|
Effect of a novel potent platelet-activating factor antagonist, modipafant, in clinical asthma.
Topics: Adult; Aged; Asthma; Dihydropyridines; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Imidazoles; Male; Middle Aged; Peak Expiratory Flow Rate; Platelet Activating Factor; Quality of Life; Single-Blind Method | 1995 |
Inhibitory effect of UK,74505, a potent and specific oral platelet activating factor (PAF) receptor antagonist, on airway and systemic responses to inhaled PAF in humans.
Topics: Administration, Inhalation; Administration, Oral; Airway Resistance; Bronchoconstriction; Dihydropyridines; Dose-Response Relationship, Drug; Double-Blind Method; Eicosanoids; Humans; Imidazoles; Leukocyte Count; Leukotriene E4; Male; Neutropenia; Neutrophils; Platelet Activating Factor; Thromboxane B2 | 1994 |
Effect of the platelet-activating factor antagonist UK-74,505 on the early and late response to allergen.
Topics: Adolescent; Adult; Allergens; Asthma; Bronchial Provocation Tests; Dihydropyridines; Double-Blind Method; Forced Expiratory Volume; Humans; Imidazoles; Male; Middle Aged; Platelet Activating Factor; Platelet Aggregation | 1993 |
26 other study(ies) available for modipafant and dihydropyridines
Article | Year |
---|---|
1,4-Dihydropyridines as antagonists of platelet activating factor. 1. Synthesis and structure-activity relationships of 2-(4-heterocyclyl)phenyl derivatives.
Topics: Animals; Dihydropyridines; Dogs; Imidazoles; Mice; Molecular Structure; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Structure-Activity Relationship | 1992 |
UK-74,505, a novel and selective PAF antagonist, exhibits potent and long lasting activity in vivo.
Topics: Animals; Blood Cells; Bronchoconstriction; Capillary Permeability; Cell Aggregation; Dihydropyridines; Dogs; Female; Guinea Pigs; Imidazoles; Male; Platelet Activating Factor; Pyridines; Rats; Rats, Inbred Strains; Time Factors | 1991 |
Substance P-induced inflammatory responses in guinea-pig skin: the effect of specific NK1 receptor antagonists and the role of endogenous mediators.
Topics: Animals; Antibodies, Monoclonal; Biphenyl Compounds; Chlorpheniramine; Dihydropyridines; Dose-Response Relationship, Drug; Edema; Female; Guinea Pigs; Imidazoles; Indoles; Inflammation; Isoindoles; Neurokinin-1 Receptor Antagonists; Pyrans; Quinolones; Skin; Substance P; Time Factors | 1995 |
Interleukin-1-induced leukocyte extravasation across rat mesenteric microvessels is mediated by platelet-activating factor.
Topics: Animals; Azepines; Cell Adhesion; Chemotaxis, Leukocyte; Dihydropyridines; Edema; Imidazoles; Inflammation; Interleukin-1; Leukocytes; Male; Mesentery; Microcirculation; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Recombinant Proteins; Skin; Triazoles | 1995 |
Pharmacological profile of UK-74,505, a novel and selective PAF antagonist with potent and prolonged oral activity.
Topics: Administration, Oral; Animals; Aorta; Azepines; Blood Platelets; Brain; Calcium Channels, L-Type; Capillary Permeability; Cattle; Dihydropyridines; Diltiazem; Gallopamil; Guinea Pigs; Hypotension; Imidazoles; In Vitro Techniques; Kinetics; Male; Membranes; Mice; Mice, Inbred Strains; Muscle Contraction; Muscle Proteins; Nitrendipine; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Potassium Chloride; Rabbits; Rats; Rats, Sprague-Dawley; Skin; Triazoles; Tritium | 1994 |
IL-1 is a potent inducer of eosinophil accumulation in rat skin. Inhibition of response by a platelet-activating factor antagonist and an anti-human IL-8 antibody.
Topics: Animals; Antibodies, Monoclonal; Calcium; Chemotaxis, Leukocyte; Dactinomycin; Dihydropyridines; Edema; Eosinophils; Imidazoles; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Interleukin-8; Leukotriene B4; Male; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Sialoglycoproteins; Skin | 1995 |
Differential effects of the PAF receptor antagonist UK-74,505 on neutrophil and eosinophil accumulation in guinea-pig skin.
Topics: Animals; Blood Proteins; Calcium; Dihydropyridines; Edema; Eosinophils; Female; Guinea Pigs; Imidazoles; Leukotriene B4; Neutrophils; Passive Cutaneous Anaphylaxis; Peritoneal Cavity; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Skin; Zymosan | 1994 |
Role of platelet-activating factor (PAF) in platelet accumulation in rabbit skin: effect of the novel long-acting PAF antagonist, UK-74,505.
Topics: Animals; Arthus Reaction; Blood Platelets; Calcium; Dihydropyridines; Edema; Fura-2; Imidazoles; In Vitro Techniques; Indium Radioisotopes; Platelet Activating Factor; Platelet Aggregation; Rabbits; Serum Albumin; Skin; Zymosan | 1993 |
Modipafant, a new PAF antagonist: pharmacokinetics and disposition in rat, dog and man.
Topics: Administration, Oral; Animals; Blood Proteins; Dihydropyridines; Dogs; Female; Humans; Imidazoles; Injections, Intravenous; Male; Platelet Aggregation Inhibitors; Protein Binding; Rats; Sex Characteristics; Tissue Distribution | 1996 |
Demonstration of reversible priming of human neutrophils using platelet-activating factor.
Topics: Adult; Azepines; Cell Adhesion; Cell Polarity; Cell Size; Cells, Cultured; Dihydropyridines; Enzyme Activation; Humans; Imidazoles; Macrophage-1 Antigen; Microspheres; N-Formylmethionine Leucyl-Phenylalanine; NADPH Oxidases; Neutrophils; Phospholipid Ethers; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Respiratory Burst; Superoxides; Time Factors; Triazoles; Tumor Necrosis Factor-alpha | 1996 |
Comparison of the reversed passive Arthus and local Shwartzman reactions of rabbit skin: effects of the long-acting PAF antagonist UK-74,505.
Topics: Animals; Arthus Reaction; Cell Aggregation; Dihydropyridines; Imidazoles; Neutrophils; Platelet Activating Factor; Rabbits; Shwartzman Phenomenon | 1997 |
Platelet-activating factor plays a pivotal role in the induction of experimental lung injury.
Topics: Animals; Capillary Permeability; Dihydropyridines; Disease Models, Animal; Elapid Venoms; Extravascular Lung Water; Female; Humans; Imidazoles; Lipopolysaccharides; Lung; Mice; Mice, Inbred BALB C; Neutrophils; Peroxidase; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Respiratory Distress Syndrome; Serum Albumin; Skin; Zymosan | 1998 |
Scorpion venom-induced neutrophilia is inhibited by a PAF receptor antagonist in the rat.
Topics: Animals; Azepines; Dihydropyridines; Drug Antagonism; Imidazoles; Leukocyte Count; Male; Neutrophil Activation; Neutrophils; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Scorpion Venoms; Triazoles | 2000 |
Effects of the PAF receptor antagonist UK74505 on local and remote reperfusion injuries following ischaemia of the superior mesenteric artery in the rat.
Topics: Animals; Azepines; Capillary Permeability; Dihydropyridines; Disease Models, Animal; Dose-Response Relationship, Drug; Imidazoles; Intestine, Small; Male; Mesenteric Artery, Superior; Neutrophils; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Polysaccharides; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Reperfusion Injury; Triazoles; Tumor Necrosis Factor-alpha | 2000 |
Blockade of PAF receptors controls interleukin-8 production by regulating the activation of neutrophil CD11/CD18.
Topics: CD11 Antigens; CD18 Antigens; Cells, Cultured; Cytochalasins; Dihydropyridines; Epitopes; Humans; Imidazoles; Interleukin-8; Neutrophil Activation; Neutrophils; Phagocytosis; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Time Factors; Zymosan | 2001 |
Role of the platelet-activating factor (PAF) receptor during pulmonary infection with gram negative bacteria.
Topics: Animals; Dihydropyridines; Female; Gram-Negative Bacteria; Imidazoles; Klebsiella Infections; Klebsiella pneumoniae; Lung; Mice; Mice, Inbred BALB C; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Tumor Necrosis Factor-alpha | 2002 |
A critical role of leukotriene B4 in neutrophil migration to infectious focus in cecal ligaton and puncture sepsis.
Topics: Animals; Cecum; Cell Movement; Dihydropyridines; Eicosanoids; Imidazoles; Indoles; Inflammation; Leukotriene B4; Leukotrienes; Lipoxygenase Inhibitors; Male; Mice; Mice, Inbred C57BL; Neutrophils; Peritoneum; Platelet Activating Factor; Prostaglandins; Time Factors; Wounds, Penetrating | 2003 |
Role of PAF receptors during intestinal ischemia and reperfusion injury. A comparative study between PAF receptor-deficient mice and PAF receptor antagonist treatment.
Topics: Animals; Dihydropyridines; Disease Models, Animal; Imidazoles; Intestinal Diseases; Intestines; Lung Diseases; Male; Mesenteric Artery, Superior; Mice; Mice, Inbred C57BL; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Reperfusion Injury | 2003 |
Sponge-induced angiogenesis and inflammation in PAF receptor-deficient mice (PAFR-KO).
Topics: Acetylglucosaminidase; Administration, Topical; Animals; Blood Vessels; Chemokines; Dihydropyridines; Fibroblasts; Granulation Tissue; Granuloma; Hemoglobins; Imidazoles; Implants, Experimental; Inflammation; Macrophages; Mice; Mice, Inbred BALB C; Mice, Knockout; Neovascularization, Pathologic; Neutrophils; Peroxidase; Platelet Activating Factor; Platelet Membrane Glycoproteins; Polyurethanes; Porifera; Receptors, G-Protein-Coupled; Skin | 2004 |
Platelet activating factor receptors drive CXC chemokine production, neutrophil influx and edema formation in the lungs of mice injected with Tityus serrulatus venom.
Topics: Animals; Chemokines, CXC; Dihydropyridines; Dose-Response Relationship, Drug; Edema; Granulocyte Colony-Stimulating Factor; Imidazoles; Interleukin-3; Lung Diseases; Male; Mice; Neutrophils; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Recombinant Fusion Proteins; Recombinant Proteins; Scorpion Venoms; Scorpions; Sulfonamides; Time Factors | 2007 |
Involvement of endogenous leukotriene B4 and platelet-activating factor in polymorphonuclear leucocyte recruitment to dermal inflammatory sites in rats.
Topics: Animals; Benzopyrans; Carboxylic Acids; Dermatitis; Dihydropyridines; Imidazoles; Leukotriene B4; Male; Neutrophil Infiltration; Neutrophils; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pneumonia; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Receptors, Leukotriene B4; Skin; Thiazoles | 2008 |
Essential role of platelet-activating factor receptor in the pathogenesis of Dengue virus infection.
Topics: Aedes; Animals; Brain; Cell Line; Cytokines; Dengue; Dengue Virus; Dihydropyridines; Disease Models, Animal; Humans; Imidazoles; Mice; Mice, Inbred BALB C; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Viral Load | 2009 |
Toll-like receptor ligands induce polymorphonuclear leukocyte migration: key roles for leukotriene B4 and platelet-activating factor.
Topics: Animals; Azepines; Cell Movement; Dihydropyridines; Female; Flagellin; Humans; Imidazoles; Leukotriene B4; Ligands; Mice; Mice, Inbred C57BL; Neutrophils; Platelet Activating Factor; Poly I-C; Propionates; Quinolines; Thienopyridines; Toll-Like Receptors; Triazoles | 2010 |
Platelet-activating factor receptor is essential for the development of experimental cerebral malaria.
Topics: Animals; Brain Chemistry; Caspase 3; Chemokines; Cytokines; Dihydropyridines; Imidazoles; Leukocytes; Lymphocyte Activation; Malaria, Cerebral; Mice; Mice, Inbred C57BL; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled | 2012 |
The role of PAF/PAFR signaling in zymosan-induced articular inflammatory hyperalgesia.
Topics: Animals; Dihydropyridines; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperalgesia; Imidazoles; Immune System Diseases; Inflammation; Joint Diseases; Leukocyte Disorders; Leukotriene B4; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Neutrophils; Platelet Activating Factor; Platelet Membrane Glycoproteins; Prostaglandins; Receptors, G-Protein-Coupled; Time Factors; Zymosan | 2013 |
Platelet Activating Factor (PAF) Receptor Deletion or Antagonism Attenuates Severe HSV-1 Meningoencephalitis.
Topics: Animals; Brain; Dihydropyridines; Herpes Simplex; Herpesvirus 1, Human; Imidazoles; Male; Meningoencephalitis; Mice; Mice, Inbred C57BL; Mice, Knockout; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Severity of Illness Index | 2016 |